Common Prescription Drug Linked to Osteoporosis Risk
New research from Johns Hopkins suggests that levothyroxine, a common thyroid medication taken by millions of Americans, may increase the risk of bone density loss, potentially leading to osteoporosis. The study found that even patients with normal thyroid-stimulating hormone levels experienced greater bone mass loss over six years. Experts recommend that patients discuss treatment risks with their doctors, as the drug may be overprescribed, particularly in older adults without hypothyroidism.